Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment

• Status: Withdrawn
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hadassah Medical Organization
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

• MS patients with esatblished relapsing remitting attacks

• increase in EDSS of at least 1 point for a least one day

Exclusion Criteria:

• children under 18

• pregnant patients

• patients with diabetes

• known allergy to steroids

• patients who received steroids within 3 months prior to the study